Unrecognized Tax Benefits of Vir Biotechnology, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Vir Biotechnology, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Vir Biotechnology, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $17,336,000, a 3.4% decline year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Vir Biotechnology, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $17,336,000 -$610,000 -3.4% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 $17,500,000 +$2,700,000 +18% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $17,200,000 +$2,800,000 +19% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $18,500,000 +$4,600,000 +33% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $17,946,000 +$4,363,000 +32% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 $14,800,000 +$1,900,000 +15% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $14,400,000 +$2,300,000 +19% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $13,900,000 +$2,600,000 +23% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $13,583,000 +$2,945,000 +28% 31 Dec 2023 10-K 23 Feb 2026 2025 FY
Q3 2023 $12,900,000 +$2,400,000 +23% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $12,100,000 +$1,500,000 +14% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $11,300,000 +$200,000 +1.8% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $10,638,000 +$3,216,000 +43% 31 Dec 2022 10-K 23 Feb 2026 2025 FY
Q3 2022 $10,500,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $10,600,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $11,100,000 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,422,000 +$2,545,000 +52% 31 Dec 2021 10-K 27 Feb 2025 2024 FY
Q4 2020 $4,877,000 +$2,152,000 +79% 31 Dec 2020 10-K 26 Feb 2024 2023 FY
Q4 2019 $2,725,000 +$321,000 +13% 31 Dec 2019 10-K 28 Feb 2023 2022 FY
Q4 2018 $2,404,000 +$2,132,000 +784% 31 Dec 2018 10-K 28 Feb 2022 2021 FY
Q4 2017 $272,000 +$253,000 31 Dec 2017 10-K 25 Feb 2021 2020 FY
Q4 2016 $19,000* 31 Dec 2016 10-K 26 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.